Nutrición Hospitalaria 00788 / http://dx.doi.org/10.20960/nh.788
Resumen| PDF (ENGLISH)

Trabajo Original

Intestinal dysfunction in the critical trauma patients – an early and frequent event


Beatriz Pinto Costa, Carla Verissimo, Marta Simões, Marisa Tomé, Manuela Grazina, Jorge Pimentel, Francisco Castro-sousa

Logo Descargas   Número de descargas: 2957      Logo Visitas   Número de visitas: 7185      Citas   Citas: 0

Compártelo:


Background: Small-bowel dysfunction exerts a relevant prognostic impact in the critically ill patients. Citrullinemia has been used in the evaluation of the intestinal function and it is considered an objective parameter of the functional enterocyte mass. Present study proposes to determine the intestinal dysfunction prevalence and the citrullinemia kinetic profile in severe trauma patients and to investigate its correlation with severity indicators and clinical outcome.Methods: A prospective study including 23 critical trauma patients was performed. Aminoacidemias were quantified, by ion exchange chromatography, at the admission and at the first and third days. Severity and outcome parameters were registered.Results: In severe trauma patients, severe hypocitrullinemia (< 20 μmol/L) prevalence at admission was high (69.6%) and mean citrullinemia was low (19.5 ± 11.1 μmol/L). Baseline citrullinemia was inversely and significantly correlated with shock index (r = -55.1%, p = 0.008) and extent of invasive ventilation support (r = -42.7%, p = 0.042). Citrullinemia < 13.7 μmol/L at admission, observed in 17.4% of patients, was associated with higher shock index (1.27 ± 0.10 versus 0.75 ± 0.18, p = 0.0001) and longer duration of invasive ventilation support (20.3 ± 7 versus 11.2 ± 7.1 days, p = 0.029) and intensive care unit stay (22 ± 5.9 versus 12.2 ± 8.8 days, p = 0.048). A citrullinemia decrease in the first day after admittance superior to 12.7% constituted a significant predictive factor of in-hospital mortality (75 versus 14.3%, p = 0.044; odds ratio = 7.8; accuracy = 65.2%; specificity = 92.3%; negative predictive value = 85.7%] and lower actuarial survival (69.8 ± 41.6 versus 278.1 ± 37.4 days, p = 0.034).Conclusions: Those results confirm the high prevalence and the prognostic relevance of hypocitrullinemia, considered a biomarker of enterocyte dysfunction, in severe trauma patients.

Palabras Clave: Citrulline. Intestinal dysfunction. Trauma. Mortality. Critically ill patients.



Lindberg G: Basic Physiology of Motility, Absorption and Secretion. Pp20-32. In Intestinal Failure: Diagnosis, Management and Transplantation. Edited by Langnas AN, Goulet O, Quiley EMM, Tappenden KA; 2008 Blackwell Publishing, Ltd, Oxford, UK; ISBN 978-1-4051-4637-1.
O’Mahony L: Immunology of the Small Intestine. Pp33-44. In Intestinal Failure: Diagnosis, Management and Transplantation. Edited by Langnas AN, Goulet O, Quiley EMM, Tappenden KA; 2008 Blackwell Publishing, Ltd, Oxford, UK; ISBN 978-1-4051-4637-1.
Wiest R, Rath HC: Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol. 2003;17:397-425.
DOI: 10.1016/S1521-6918(03)00024-6
Klingensmith NJ, Coopersmith CM: The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness. Crit Care Clin. 2016;32:203-12.
Reintam Blaser A, Jakob SM, Starkopf J: Gastrointestinal failure in the ICU. Curr Opin Crit Care. 2016;22:128-41.
Piton G, Capellier G: Biomarkers of gut barrier failure in the ICU. Curr Opin Crit Care. 2016;22:152-60.
Piton G, Belon F, Cypriani B, Regnard J, Puyraveau M, Manzon C, Navellou JC, Capellier G: Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality. Crit Care Med. 2013;41:2169-76.
Reintam Blaser A, Poeze M, Malbrain ML, Björck M, Oudemans-van Straaten HM, Starkopf J; Gastro-Intestinal Failure Trial Group: Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study. Intensive Care Med. 2013;39:899-909.
Reintam A, Parm P, Kitus R, Starkopf J, Kern H: Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care. 2008;12:R90.
Crenn P, Messing B, Cynober L: Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008;27:328-39.
Curis E, Crenn P, Cynober L: Citrulline and the gut. Curr Opin Clin Nutr Metab Care. 2007;10: 620-6.
Cynober L: Citrulline: just a biomarker or a conditionally essential amino acid and a pharmaconutrient in critically ill patients? Crit Care. 2013;17:122.
Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G: Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med. 2011;37:911-7.
Intensive Care Society: Levels of Critical Care for Adult Patients – Intensive Care Society. http://www.ics.ac.uk/ics-homepage/guidelines-and-standards/. 2014. Assessed in September 23, 2015.
O'Grady JG, Schalm SW, Williams R: Acute liver failure: redefining the syndromes. Lancet. 1993;342:273-5.
Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerves A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL–CLIF Consortium: Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426-37.
World Medical Association: World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. http://www.wma.net/en/30publications/10policies/b3/17c.pdf. 2008. Assessed in September 23, 2015.
Fagon JY, Chastre J, Novara A, Medioni P, Gibert C: Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med. 1993;19:137-44.
Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957-63.
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.
DOI: 10.1007/BF01709751
Baker SP, O'Neill B, Haddon W Jr, Long WB: The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-96.
Champion HR, Sacco WJ, Copes WS, Gann DS, Gennarelli TA, Flanagan ME: A revision of the Trauma Score. J Trauma. 1989;29:623-9.
Rady MY, Smithline HA, Blake H, Nowak R, Rivers E: A comparison of the shock index and conventional vital signs to identify acute, critical illness in the emergency department. Ann Emerg Med. 1994;24:685-90.
Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32.
Schag CC, Heinrich RL, Ganz PA: Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2:187-93.
Le Boucher J, Charret C, Coudray-Lucas C, Giboudeau J, Cynober L: Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A. Clin Chem. 1997;43:1421-8.
Sertaridou E, Papaioannou V, Kolios G, Pneumatikos I: The gut failure in critical care: old school versus new school. Ann Gastroenterol. 2015;28:309-322.
Schmid-Schönbein GW, Chang M: The autodigestion hypothesis for shock and multi-organ failure. Ann Biomed Eng. 2014;42:405-14.
Shen LJ, Guan YY, Wu XP, Wang Q, Wang L, Xiao T, Wu HR, Wang JG: Serum citrulline as a diagnostic marker of sepsis-induced intestinal dysfunction. Clin Res Hepatol Gastroenterol. 2015;39:230-6.
Crenn P, Neveux N, Chevret S, Jaffray P, Cynober L, Melchior JC, Annane D; COIITSS Study Group: Plasma L-citrulline concentrations and its relationship with inflammation at the onset of septic shock: a pilot study. J Crit Care. 2014;29:315.e1-6.
Piton G, Manzon C, Monnet E, Cypriani B, Barbot O, Navellou JC, Carbonnel F, Capellier G: Plasma citrulline kinetics and prognostic value in critically ill patients. Intensive Care Med. 2010;36:702-6.
Blasco-Alonso J, Sánchez Yáñez P, Rosa Camacho V, Camacho Alonso JM, Yahyaoui Macías R, Gil-Gómez R, Milano Manso G: Citrulline and arginine kinetics and its value as a prognostic factor in pediatric critically ill patients. An Pediatr (Barc). 2015;83:257-63.
van Waardenburg DA, de Betue CT, Luiking YC, Engel M, Deutz NE: Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. Am J Clin Nutr. 2007;86:1438-44.
Grimaldi D, Guivarch E, Neveux N, Fichet J, Pène F, Marx JS, Chiche JD, Cynober L, Mira JP, Cariou A: Markers of intestinal injury are associated with endotoxemia in successfully resuscitated patients. Resuscitation. 2013;84:60-5.
Noordally SO, Sohawon S, Semlali H, Michely D, Devriendt J, Gottignies P: Is there a correlation between circulating levels of citrulline and intestinal dysfunction in the critically ill? Nutr Clin Pract. 2012;27:527-32.

Artículos más populares

Revisión: Ayuno intermitente: efectos en diversos escenarios clínicos

Introducción: los esquemas de ayuno intermitente (...

Publicado: 2023-05-24

Trabajo Original: Body mass index and risk of inflammatory breast disease: a Mendelian randomization study

Introduction: in previous studies, obesity was ide...

Publicado: 2023-04-22

Revisión: Relación entre la dieta, aspectos nutricionales y la calidad del sueño en población pediátrica

.La relación entre la dieta y el sueño ha sido esc...

Publicado: 2023-06-08

Una cookie o galleta informática es un pequeño archivo de información que se guarda en su navegador cada vez que visita nuestra página web. La utilidad de las cookies es guardar el historial de su actividad en nuestra página web, de manera que, cuando la visite nuevamente, ésta pueda identificarle y configurar el contenido de la misma en base a sus hábitos de navegación, identidad y preferencias. Las cookies pueden ser aceptadas, rechazadas, bloqueadas y borradas, según desee. Ello podrá hacerlo mediante las opciones disponibles en la presente ventana o a través de la configuración de su navegador, según el caso. En caso de que rechace las cookies no podremos asegurarle el correcto funcionamiento de las distintas funcionalidades de nuestra página web. Más información en el apartado “POLÍTICA DE COOKIES” de nuestra página web.